                         SEQUENCE LISTING

<110>  GlaxoSmithKline Biologicals S.A.
 
<120>  Immunogenic Composition

<130>  VB66389A

<140>  US 62/686889
<141>  2018-06-19

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  160
<212>  PRT
<213>  Artificial

<220>
<223>  Haemophilus Influenzae

<400>  1

Met Lys Lys Ile Ile Leu Thr Leu Ser Leu Gly Leu Leu Thr Ala Cys 
1               5                   10                  15      


Ser Ala Gln Ile Gln Lys Ala Lys Gln Asn Asp Val Lys Leu Ala Pro 
            20                  25                  30          


Pro Thr Asp Val Arg Ser Gly Tyr Ile Arg Leu Val Lys Asn Val Asn 
        35                  40                  45              


Tyr Tyr Ile Asp Ser Glu Ser Ile Trp Val Asp Asn Gln Glu Pro Gln 
    50                  55                  60                  


Ile Val His Phe Asp Ala Val Val Asn Leu Asp Lys Gly Leu Tyr Val 
65                  70                  75                  80  


Tyr Pro Glu Pro Lys Arg Tyr Ala Arg Ser Val Arg Gln Tyr Lys Ile 
                85                  90                  95      


Leu Asn Cys Ala Asn Tyr His Leu Thr Gln Val Arg Thr Asp Phe Tyr 
            100                 105                 110         


Asp Glu Phe Trp Gly Gln Gly Leu Arg Ala Ala Pro Lys Lys Gln Lys 
        115                 120                 125             


Lys His Thr Leu Ser Leu Thr Pro Asp Thr Thr Leu Tyr Asn Ala Ala 
    130                 135                 140                 


Gln Ile Ile Cys Ala Asn Tyr Gly Glu Ala Phe Ser Val Asp Lys Lys 
145                 150                 155                 160 


